Join
Live feed
·
INSIDERFilingvia Quantisnow
Cumberland Pharmaceuticals Inc. logo

Director Jones James bought $807 worth of shares (168 units at $4.80), increasing direct ownership by 0.39% to 43,336 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CPIX· Cumberland Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CPIX (Cumberland Pharmaceuticals Inc.) and more on Quantisnow.